Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €60.00 | €81.53 | 35.881% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €66.50 | €79.43 | 19.443% |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.70 | - | - |
| TG Therapeutics Inc. | 20 | 4 | 4 | 0 | €14.95 | €27.00 | 80.552% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €38.80 | €46.08 | 18.769% |
| G1 Therapeutics | 14 | 1 | 2 | 0 | €4.16 | €10.56 | 153.822% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.93 | €8.39 | 333.844% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €16.56 | €28.17 | 70.095% |
| Insmed Inc. | 13 | 1 | 2 | 1 | €23.20 | €44.01 | 89.684% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.48 | €20.00 | 38.122% |
| Geron Corp. | 11 | 0 | 3 | 0 | €3.72 | €4.60 | 23.635% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.21 | €23.46 | 65.122% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.00 | €13.74 | 1271.477% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| Corcept Therapeutics Inc. | 9 | 0 | 3 | 0 | €24.51 | €35.38 | 44.341% |
| Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.22 | €4.57 | 106.399% |
| Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €4.29 | €10.96 | 155.262% |
| WAVE Life Sciences Ltd | 8 | 0 | 0 | 0 | €5.45 | €9.10 | 66.987% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.38 | €5.76 | 70.308% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.72 | €4.63 | 545.649% |
| Immunogen Inc. | 7 | 0 | 1 | 0 | €28.97 | - | - |
| BeiGene Ltd ADR | 8 | 1 | 1 | 0 | €150.00 | €255.89 | 70.593% |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.89 | €2.81 | 48.695% |